Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Phacoemulsification Combined Glaucoma Surgeries in the Treatment of Nanophthalmos Combined with Angle Closure Glaucoma
Author Affiliations & Notes
  • Jin Wang
    ophthalmology, University of California San Diego, La Jolla, California, United States
    Beijing Tongren Hospital CMU, Beijing, China
  • Dapeng Mou
    Beijing Tongren Hospital CMU, Beijing, China
  • Ningli Wang
    Beijing Tongren Hospital CMU, Beijing, China
  • Xin Tang
    Beijing Tongren Hospital CMU, Beijing, China
  • Footnotes
    Commercial Relationships   Jin Wang None; Dapeng Mou None; Ningli Wang None; Xin Tang None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2083. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jin Wang, Dapeng Mou, Ningli Wang, Xin Tang; Phacoemulsification Combined Glaucoma Surgeries in the Treatment of Nanophthalmos Combined with Angle Closure Glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2083.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the efficacy and safety of phacoemulsification combined with different glaucoma surgery strategies in nanophthalmos secondary to angle closure glaucoma (NSACG)

Methods : This retrospective interventional case series study collected medical records of patients diagnosed with NSACG with peripheral anterior synechiae (PAS) ≥180° between December 2011 and June 2021 at Beijing Tongren Hospital, Beijing, China. All the participants were further divided into 2 groups based on the AL and the surgical interventional procedures. Group 1 is defined as NSACG patients with an AL<20mm and ≥ 17.0mm underwent PEI+VGP+PPV (PVP) with Trabeculectomy (Trab) or Endoscopic photocoagulation (ECP). Group 2 is defined as NSACG patients with an AL <17mm, and underwent PEI+VGP+PPV+ Trab +Sclerectomy (PVPTS). The primary outcome is the proportion of patients with IOP ≤21 mmHg with or without ocular hypotensive medication OR those with a ≥ 20% reduction in IOP from baseline.

Results : 31 eyes of 22 patients were enrolled in our study with a mean follow-up period of 50.2±26.2 months. The mean age was 39.59±11.59 years, and the mean AL was 17.21±1.44mm. Among them, 13 eyes of 7 patients and 18 eyes of 15 patients were divided into Group 1 and Group 2, respectively. Compared to group 1 with longer AL, participants with extremely short AL tend to have worse PVA and BCVA (P=0.020 and P=0.026, respectively), more IOP-lowering medications (P=0.007), and shorter follow-up times (P=0.004). PVP combined with Trab or ECP can significantly reduce IOP (P<0.001) and the number of IOP-lowering medications (P=0.034) in NSACG patients with AL <20mm and ≥ 17.0mm, with 92.3% eyes had IOP drop rate≥20% and 69.2% eyes had IOP controlled under 21mmHg. For NSACG patients with extremely short AL <17mm, PVPTS can also significantly reduce IOP (P<0.001), and the number of IOP-lowering medications (P =0.007) with 94.4% of eyes had IOP drop rate≥20% and 77.8% of eyes achieved IOP controlled. There is no eye occurred postoperative malignant glaucoma in either group.

Conclusions : PVP combined with Trab or ECP and PVPTS are two effective and safe surgical intervention strategies for patients with NSACG. Surgeries applied using the new criteria can generally achieve better IOP control outcomes with lower complication rates.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×